Abbott Receives FDA Approval for Minimally Invasive Portico ™ with FlexNav™ TAVR System to Treat Patients with Aortic Valve Disease

- Transcatheter aortic valve replacement (TAVR) procedure treats people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery
Source: Abbott.com - Category: Pharmaceuticals Source Type: news